Condition

Resected Pancreatic Adenocarcinoma clinical trials and research

• 2Clinical trials
• 10Countries

All recruiting trials (2)

• Daraxonrasib after surgery for resected pancreatic ductal adenocarcinoma (PDAC)

  This trial tests whether taking daraxonrasib after surgery can help prevent cancer from coming back in adults with resected PDAC who completed perioperative chemotherapy.

  Recruiting at 85 sites Phase 3 Revolution Medicines, Inc. · Birmingham, Alabama and 85 other locations · NCT07252232

• Stage-guided adjuvant chemotherapy after surgery for pancreatic cancer treated with neoadjuvant mFOLFIRINOX

  This trial tests whether choosing adjuvant chemotherapy by tumor stage—either gemcitabine plus nab‑paclitaxel or continued mFOLFIRINOX—helps people with resected pancreatic adenocarcinoma who received 3 months of neoadjuvant mFOLFIRINOX.

  Recruiting Phase 2/3 University Hospital, Rouen · Rouen · NCT07044453

Related topics

Quick answers

How many Resected Pancreatic Adenocarcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in France (2 trials), Canada (1 trial), Germany (1 trial), Italy (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →